Anti-TNF treatment of reactive arthritis. A monocentric experience

Joint Bone Spine. 2017 Mar;84(2):237-238. doi: 10.1016/j.jbspin.2016.02.022. Epub 2016 May 25.
No abstract available

Keywords: Anti-TNF agents; Reactive arthritis; Spondyloarthritis; Treatment.

Publication types

  • Letter

MeSH terms

  • Adalimumab / administration & dosage
  • Adult
  • Arthritis, Reactive / diagnosis
  • Arthritis, Reactive / drug therapy*
  • Cohort Studies
  • Etanercept / administration & dosage
  • Female
  • Follow-Up Studies
  • Humans
  • Infliximab / administration & dosage
  • Male
  • Middle Aged
  • Retrospective Studies
  • Spondylarthritis / diagnosis
  • Spondylarthritis / drug therapy*
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*
  • Tumor Necrosis Factor-alpha / therapeutic use
  • Young Adult

Substances

  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Adalimumab
  • Etanercept